Literature DB >> 4195608

Plaque size heterogeneity: a genetic trait of lymphocytic choriomeningitis virus.

A J Pulkkinen, C J Pfau.   

Abstract

All of the ten strains of lymphocytic choriomeningitis virus assayed on BHK 21/13S cells showed various degrees of plaque size heterogeneity. The amount of virus released from these plaques was usually very small because of rapid photodynamic inactivation by neutral red. When virus from large and small plaques of a specific strain was plated, the same distribution of plaque size was obtained from each clone. Although it was shown that surface virus could possibly be randomly distributed at the time of addition of neutral red overlays, no virus could be isolated from nonplaque areas. Two different strains of virus (CA1371 and WE) with markedly different plaque size ranges were separated by plaque excision from plates infected with a mixture of both viruses.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4195608      PMCID: PMC376879          DOI: 10.1128/am.20.1.123-128.1970

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  22 in total

1.  THE PATHOGENESIS OF LYMPHOCYTIC CHORIOMENINGITIS IN MICE: THE EFFECTS OF DIFFERENT INOCULATION ROUTES AND THE FOOTPAD RESPONSE.

Authors:  J HOTCHIN; L BENSON
Journal:  J Immunol       Date:  1963-10       Impact factor: 5.422

2.  Lymphocytic choriomeningitis infection of mice as a model for the study of latent virus infection.

Authors:  J E HOTCHIN; M CINITS
Journal:  Can J Microbiol       Date:  1958-04       Impact factor: 2.419

3.  [Complement-fixing antibodies against the virus of lymphocytic choriomeningitis in serum of test animals and observation on immunity].

Authors:  I HANSEN; K A JOCHHEIM; G LIEDTKE; W SCHEID; G STAUSBERG
Journal:  Arch Gesamte Virusforsch       Date:  1957

4.  A persistent and inapparent infection of L cells with the virus of lymphocytic choriomeningitis.

Authors:  F Lehmann-Grube; W Slenczka; R Tees
Journal:  J Gen Virol       Date:  1969-07       Impact factor: 3.891

5.  Rabies and lymphocytic choriomeningitis virus (LCMV) infection of tissue culture; enhancing effect of LCMV.

Authors:  T J Wiktor; M M Kaplan; H Koprowski
Journal:  Ann Med Exp Biol Fenn       Date:  1966

6.  Inhibition of lymphocytic choriomeningitis virus multiplication by 2-(alpha-hydroxybenzyl)benzimidazole.

Authors:  C J Pfau; K P Camyre
Journal:  Virology       Date:  1968-07       Impact factor: 3.616

7.  Inhibition of lymphocytic choriomeningitis virus replication by actinomycin D and 6-azauridine.

Authors:  L L Buck; C J Pfau
Journal:  Virology       Date:  1969-04       Impact factor: 3.616

8.  Plaque assay for lymphocytic choriomeningitis virus based on hemadsorption interference.

Authors:  S Wainwright; C A Mims
Journal:  J Virol       Date:  1967-10       Impact factor: 5.103

9.  Cells persistently infected with newcastle disease virus: I. Properties of mutants isolated from persistently infected L cells.

Authors:  H Thacore; J S Youngner
Journal:  J Virol       Date:  1969-09       Impact factor: 5.103

10.  IN VIVO ANTIVIRAL ACTIVITY OF 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA.

Authors:  R W SIDWELL; G J DIXON; S M SELLERS; F M SCHABEL
Journal:  Appl Microbiol       Date:  1965-07
View more
  17 in total

1.  Lymphocytic choriomeningitis virus-induced disease of the central nervous system and the "antigen-sink" hypothesis.

Authors:  D C Pevear; F Melio; C J Pfau
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

2.  Establishment and characterization of ferret cells in culture.

Authors:  R S Trowbridge; J Lehmann; P Brophy
Journal:  In Vitro       Date:  1982-11

3.  Cells that express viral antigens but lack H-2 determinants are not lysed by immune thymus-derived lymphocytes but are lysed by other antiviral immune attack mechanisms.

Authors:  R M Zinkernagel; M B Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

4.  Characteristics of the in vitro inhibition of arenavirus synthesis by bis-benzimidazoles.

Authors:  J P Stella; K D Yankaskas; J H Morgan; M P Fox; C J Pfau
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

5.  Evaluation of bis-benzimidazoles in the treatment of murine lymphocytic choriomeningitis virus infections.

Authors:  J P Stella; J Michaelson; S L Dorfman; J H Morgan; C J Pfau
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

6.  Immunosuppression-induced susceptibility of inbred hamsters (Mesocricetus auratus) to lethal-disease by lymphocytic choriomeningitis virus infection.

Authors:  E V Genovesi; C J Peters
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

7.  Arenaviruses: cellular response to long-term in vitro infection with parana and lymphocytic choriomeningitis viruses.

Authors:  L D Staneck; R S Trowbridge; R M Welsh; E A Wright; C J Pfau
Journal:  Infect Immun       Date:  1972-10       Impact factor: 3.441

8.  Necrosis of adipose tissue induced by sequential infections with unrelated viruses.

Authors:  H Y Yang; I Joris; G Majno; R M Welsh
Journal:  Am J Pathol       Date:  1985-08       Impact factor: 4.307

Review 9.  A comparison of biochemical and biological properties of standard and defective lymphocytic choriomeningitis virus.

Authors:  R M Welsh; P A Burner; J J Holland; M B Oldstone; H A Thompson; L P Villarreal
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

10.  Lytic and turbid plaque-type mutants of lymphocytic choriomeningitis virus as a cause of neurological disease or persistent infection.

Authors:  J Hotchin; W Kinch; L Benson
Journal:  Infect Immun       Date:  1971-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.